可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Kalina A, Csaszer A, Fust G, et al. The association of serum lipoprotein (a) levels, apolipoprotein (a) size and (TTTTA) n
polymorphism with coronary heart disease [J] . Clin Chim Acta, 2001, 309(1):45-51.
[2] Gaw A, Brown EA, Docherty G, et al. Is lipoprotein (a) cholesterol a better predictor of vascular disease events than total lipoprotein (a) mass ? A nested case control study from The West of Scotland Coronary Prevention Study [J]. Atherosclerosis, 2000, 148:95-100.
[3] Cantin B, Gagnon F, Moorjani S, et al. Lipoprotein (a) and independent risk factor for ischaemic heart disease in men ? The Quebec Cardiovascular Study [J] . J Am Coll Cardiol, 1998, 31:519-525.
[4] Hopkins P, Hunt S, Schiner P, et al. Lipoprotein (a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Familly Heart Study [J] . Atherosclerosis, 1998, 141:333-345.
[5] Mary S, Ayrs S, Humphrie S, et al. Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men [J] . Am J Med, 2001, 110(1):22-27.
[6] Von Eckardstein, Schulte H, Cullen P, et al. Lipoprotein (a) farther increase the risk of coronary events in men with high global cardiovascular risk [J] . J Am Coll Cardiol, 2001, 37(2):434-439.
[7] 刘松岩, 杨欣国, 侯允天. 血清脂蛋白(a)水平与冠状动脉狭窄及心绞痛类型的关系 [J] . 心脏杂志, 2001, 13(6):463-460.
[8] Buechler C, Vllrich H. Lipoprotein (a) up- regulates the expression of the plasminogen activator inhibitor 2 inhuman blood monocytes [J] . Blood, 2001, 97(4):981-986.
[9] Lundstam O, HartCamejo G. Proteoglycans' contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix [J] . Arterioscler Thromb Vasc Biol, 1999, 19:1162-1167.